Register
Register
Register

9Bio Therapeutics

Start-up

www.9biotx.comQuebec, Canada
4 profile visits

About

9Bio Therapeutics is a biotech company committed to developing innovative oncology therapeutics. Our AI-guided structural biology platform integrates anatomical and biochemical contexts to design drugs that selectively target tumors. Using this approach, we generate medicines with specificity for tumors that spare healthy tissues, improving safety, efficacy, and opening the door to previously underexploited therapeutic modalities. Our pipeline includes two discovery-stage therapies: an antibody-drug conjugate (ADC) targeting chemoresistant tumor cells and an ADC targeting tumor-subverted immune cells.

Mission: Cancer

HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancersHORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients

Representatives

Founder, President, CSO

9Bio Therapeutics

Marketplace (1)

  • Project cooperation

    Computationally Designed Tumor-Selective Antibodies & ADCs for Precision Oncology

    We seek a precision oncology cancer consortium and aim to provide tumor-selective antibodies, ADCs, and advanced computational design.

    • Offering Expertise to Consortias
    • Design - setting the project scope
    • Ideation - identifying the project idea
    • Drafting - writing the project proposal
    • HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
    • HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
    • HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
    • HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
    • HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
    • HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
    • HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)
    Author

    Founder, President, CSO at 9Bio Therapeutics

    Quebec, Canada